• Most Popular
  • Most Shared

FDA OKs Concerta for attention deficit in adults

CHICAGO
Fri Jun 27, 2008 1:16pm EDT

CHICAGO (Reuters) - Johnson & Johnson said on Friday U.S. health regulators approved Concerta to treat adults with attention deficit hyperactivity disorder, or ADHD.

Health  |  Stocks  |  Global Markets

The U.S. Food and Drug Administration approved the drug, generically known as methylphenidate, for adults aged 18 to 65 in doses of 18 to 72 mg daily.

ADHD is the most common emotional, cognitive and behavioral disorder treated in children and, according to the National Institute of Mental Health, between 30 and 70 percent of children with ADHD continue to exhibit symptoms as adults.

ADHD is thought to affect about 8 million, or one in 20, adults in the United States.

(Reporting by Debra Sherman; Editing by Andre Grenon)
Health
Stocks
Global Markets


More from Reuters

Photo

U.S. probing if al Qaeda linked to airplane incident

WASHINGTON (Reuters) - The United States is investigating whether al Qaeda was involved in a Christmas Day attempt to blow up a passenger jet, but there is no early evidence the Nigerian suspect in the case was part of a larger plot, the U.S. homeland security chief said on Sunday. | Video

» More Top News
A Delta Airbus 330 airliner sits on a runway at Detroit Metropolitan Airport in Romulus, Michigan in this video grab made December 25, 2009. Credit: REUTERS/WDIV TV/Handout

The battle in mid-air

The attraction of bombing airliners means the aviation industry has to be constantly vigilant in its fight against attackers.  Full Article 

U.S.
A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
Political Risk in 2010:

Don't say we didn't warn you

With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

Global Markets